A new treatment for amyotrophic lateral sclerosis, or ALS, has been approved by the US Food and Drug Administration.
The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on T… [read more]
Blog
A new treatment for amyotrophic lateral sclerosis, or ALS, has been approved by the US Food and Drug Administration.
The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on T… [read more]
/cdn.vox-cdn.com/uploads/chorus_asset/file/23951350/STK043_VRG_Illo_N_Barclay_6_Meta.jpg)
/cdn.vox-cdn.com/uploads/chorus_asset/file/25199634/121223_CES_2024_MSI_Titan_18_laptop_ADiBenedetto_0006.jpg)